Barclays’s Jaguar Health JAGX Stock Holding History

Barclays’s Portfolio JAGX Stock Details JAGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$168	Buy	+56	New	+$361	﹤0.01%	5136
2021 Q2	–	Hold	0	–	-$151K	–	4971
2021 Q1	–	Hold	0	–	–	–	3825
2020 Q1	–	Hold	0	–	–	–	6301
2019 Q4	–	Hold	0	–	–	–	6574
2018 Q3	–	Hold	0	–	-$14K	–	7254
2018 Q2	–	Hold	0	–	–	–	6376
2018 Q1	–	Hold	0	–	–	–	5552

Other funds holding JAGX

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Barclays's JAGX Position: Q2 2026 in Review

Barclays opened a new position in Jaguar Health (JAGX) in Q2 2026: 56 shares worth $168. The stake represents ﹤0.01% of the portfolio and ranks #5136 among its holdings.

8 funds tracked by Wall St. Rank hold JAGX as of Q2 2026.

Barclays held 56 shares of Jaguar Health worth $168 as of Q2 2026.
Jaguar Health was a new Barclays position in Q2 2026.
Jaguar Health made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5136 holding.
8 funds tracked by Wall St. Rank held Jaguar Health as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.